XERS - Xeris Pharmaceuticals' (XERS) CEO Paul Edick on Q1 2020 Results - Earnings Call Transcript
Xeris Pharmaceuticals, Inc. (XERS)
Q1 2020 Earnings Conference Call
May 7, 2020 8:30 AM ET
Company Participants
Allison Wey – Senior Vice President-Investor Relations and Corporate Communication
Paul Edick – Chairman and Chief Executive Officer
Barry Deutsch – Chief Financial Officer
Conference Call Participants
Randall Stanicky – RBC Capital Markets
Dan Clark – Mizuho Securities
David Amsellem – Piper Sandler
Presentation
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Xeris Pharmaceuticals First Quarter 2020 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
I